[LIPO] YoY Quarter Result on 31-Dec-2022 [#Q4]

Stock
[LIPO] Lipella Pharmaceuticals Inc.
Announcement Date
31-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 49.09%
YoY- 5.71%
Quarter Report
LIPO's Result
LIPO's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 CAGR
Revenue 121 151 26 115.72%
PBT -689 -364 -385 33.77%
Tax -58,388 -1 -57 3100.54%
NP -689 -363 -385 33.77%
Tax Rate - - - -
Total Cost 810 514 411 40.38%
Ratio Analysis
31/12/23 31/12/22 31/12/21 CAGR
NP Margin -570.07 -240.25 -1,486.38 -38.07%
Per Share
31/12/23 31/12/22 31/12/21 CAGR
EPS -0.11 -0.06 -0.07 25.35%
EPS Diluted -0.11 -0.06 -0.07 25.35%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.